# Pharmacoepidemiology and Drug Safety

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/pharmacoepidemiology-and-drug-safety/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1053-8569 |
| ISSNs | 1053-8569,1099-1557 |
| OpenAlex ID | https://openalex.org/S140231191 |
| Publisher | Wiley |

## Journal papers

Showing 12 of 28.

- [A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions](https://scholariq.org/papers/a-comparison-of-measures-of-disproportionality-for-signal-detection-in/)
- [The reporting odds ratio and its advantages over the proportional reporting ratio](https://scholariq.org/papers/the-reporting-odds-ratio-and-its-advantages-over-the-proportional-reporting/)
- [Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint <scp>ISPOR‐ISPE</scp> Special Task Force on real‐world evidence in health care decision making](https://scholariq.org/papers/good-practices-for-real-world-data-studies-of-treatment-and-or-comparative-2/)
- [The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan](https://scholariq.org/papers/the-chang-gung-research-database-a-multi-institutional-electronic-medical/)
- [The importance of defining periods of complete mortality reporting for research using automated data from primary care](https://scholariq.org/papers/the-importance-of-defining-periods-of-complete-mortality-reporting-for-research/)
- [The incident user design in comparative effectiveness research](https://scholariq.org/papers/the-incident-user-design-in-comparative-effectiveness-research/)
- [Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‐analysis](https://scholariq.org/papers/frequency-of-adverse-drug-reactions-in-hospitalized-patients-a-systematic-review/)
- [The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people](https://scholariq.org/papers/the-pattern-of-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-from-1997-to/)
- [Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU Project](https://scholariq.org/papers/exposure-to-benzodiazepines-anxiolytics-hypnotics-and-related-drugs-in-seven/)
- [Establishment of the MID‐NET<sup>®</sup> medical information database network as a reliable and valuable database for drug safety assessments in Japan](https://scholariq.org/papers/establishment-of-the-mid-net-sup-sup-medical-information-database-network-as-a/)
- [The Asian Pharmacoepidemiology Network (AsPEN): promoting multi‐national collaboration for pharmacoepidemiologic research in Asia](https://scholariq.org/papers/the-asian-pharmacoepidemiology-network-aspen-promoting-multi-national/)
- [Effect of non‐steroidal anti‐inflammatory drugs on non‐melanoma skin cancer incidence in the SKICAP‐AK trial](https://scholariq.org/papers/effect-of-non-steroidal-anti-inflammatory-drugs-on-non-melanoma-skin-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.